Cytotoxic and inhibitory effects of 4,4′-dihydroxy chalcone (RVC-588) on proliferation of human leukemic HL-60 cells

Leukemia Research

Volumn 27, Issue 1, 2003, Pages 57-64

  Saydam, Guray ^a   Aydin, H Hakan ^a   Sahin, Fahri ^a   Kucukoglu, Ozlem ^a   Erciyas, Ercin ^a   Terzioglu, Ender ^a   Buyukkececi, Filiz ^a   Omay, Serdar Bedii ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

4,4 Dihydroxy chalcone; Chalcones; Cytotoxicity; HL 60 cells; RVC 588

Indexed keywords

AGAROSE; CD11 ANTIGEN; CD11B ANTIGEN; CD14 ANTIGEN; CELL SURFACE MARKER; DNA FRAGMENT; GLYCOPROTEIN; GLYCOPROTEIN P 15095; S NITROSOGLUTATHIONE; TRYPAN BLUE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOTOXICITY; DNA DEGRADATION; DNA STRAND BREAKAGE; DRUG EFFECT; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA; LEUKEMIA CELL LINE; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STRUCTURE ANALYSIS;

ACETOPHENONES; ANTIGENS, CD11B; ANTIGENS, CD14; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZYLIDENE COMPOUNDS; CELL DIFFERENTIATION; CELL DIVISION; CHALCONE; CHALCONES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; MOLECULAR STRUCTURE; NICOTINIC ACIDS;

EID: 0037212056     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00058-9     Document Type: Article

References (26)

1. Hsieh H.K., Lee T.H., Wang J.P., Way J.J., Lin C.N. Synthesis and anti-inflammatory effect of chalcones and related compounds. Pharmacol. Res. 15:1998;39.
2. Torigoo T., Arisawa M., Iloch S., Fujiu M., Mayuyama H.B. Anti-mutagenic chalcones: antagonising the mutagenicity of benzo(a)pyrene in Salmonella typhymurium. Biochem. Biophys. Res. Commun. 112:1983;833.
3. Satyanarayana K., Rao M.N.A. Anti-inflammatory, analgesic and anti-pyretic activities of 3-(4-(3-(4-dimethylaminophenyl)-1-oxo-2-propenyl) phenyle)sydrone. Indian Drugs. 30:1993;313.
4. Torigoo T, Arisawa M, Iloch S, Fujiu M, Mayuyama HB. Anti-mutagenic chalcones: Antagonising the mutagenicity of benzo(a)pyrene in Salmonella typhymurium. Biochem Biophys Res Commun 1983;112:833.
5. Anto R.J., Sukumaran K., Kuttan G., Rao M.N.A., Subbaraju V., Kuttan R. Anticancer and anti-oxidant activity of synthetic chalcones and related compounds. Cancer Lett. 97:1995;33.
6. Haruguchi H., Ishikawa H., Mizutani K., Tamura Y., Kinoshita T. Anti-oxidative and superoxide scavering activities of retrochalcones in Glycyrrhiza inflata. Bioorg. Med. Chem. 6:1998;339.
7. Ruby A.J., Kuttan G., Sathyanarayama K., Rao M.N.A. Tumor reducing and anti-oxidant activities of synthane-substituted chalcones. J. Clin. Biochem. Nutr. 17:1994;73.
8. Wattenberg LW, Coccia JB, Galhaith AR. Inhibition of carcinogen-induced pulmonary and mammary carcinogenesis by chalcones administered after carcinogen exposure. Cancer Lett. 1994;83:165.
9. Edwards ML, Stemerick DM, Sunkara SP. Chalcone derivatives useful in controlling growth of tumor tissue and their preparation. Eur Pat Appl EP 288,794, 2 November 1988; Chem Abstr 111, 17706t.
10. Vincenzo R.D., Ferlini C., Distefano M., Gaggini C., Riva A., Bombardelli E.et al. In vitro evaluation of newly developed chalcone analogues in human cancer cells. Cancer Chem. Pharmacol. 46:2000;305.
11. Sukumaran K., Kuttan R. Screening of 11 ferns of cytotoxic and antitumor potential with special reference of Pityrogramma calomelanos. J. Ethnopharmacol. 36:1991;93.
12. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet R, Sigman CC. Chemopreventive drug development; perspective and progress. Cancer Epidemiol, Biomark Prev 1994;3:85.
13. Dimmock J.R., Kumar P. Anticancer and cytotoxic properties of Mannich bases. Curr. Med. Chem. 4:1997;1.
14. Dimmock J.R., Kandepu N.M., Hetherington M., Quail J.W., Pugazhenti U., Sudom A.M.et al. Cytotoxic activities of mannich bases of chalcones and related compounds. J. Med. Chem. 41:1998;1014.
15. Gordon L.T., Weitzman S.A. Inflammation and cancer. Cancer J. 6:1993;257.
16. Suolinna E.M., Buchsbaum R.N., Recker E. The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Res. 35:1975;1865.
17. Chiou G.C., Yao Q.S., Varma R.S. Inhibition of ocular inflammation by chalcone derivatives and prednisolone. J. Ocular Pharmacol. 8:1992;213.
18. Böhme H., Hartke K. Über die Spaltung von aminalen und α-dialkylamino-athern mit carbonsaurehalogeniden. Chem. Ber. 93:1960;1305.
19. Vorlander D. Acid, salt, ester and addition product. Ber. Dtsch. Chem. 58:1925;118.
20. Yit C.C., Das N.P. Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Lett. 82:1994;65.
21. Collins S.J., Bonder A., Ting R., Gallo R.C. Induction of morphological and functional differentiation of human promyelocyte leukemia cells (HL-60) by compound which induce differentiation of murine leukemia cells. Int. J. Cancer. 25:1980;213.
22. 3 and phorbol-12-myristate-13 acetate. Cancer Res. 43:1983;4989.
23. Foon K.A., Schroff M.A., Gale R.P. Surface markers on leukemia and lymphoma: recent advancer. Blood. 60:1982;1.
24. Takahashi T., Kobori M., Shinmoto H., Tsushida T. Structure-activity relationship of flavonoids and the induction of granulocytic-or monocytic-differentiation in HL-60 human myleoid leukemia cells. Biosci. Biotechnol. Biochem. 62:1998;2199.
25. Lee S.K., Song L., Mata-Greenwood E., Kelloff G.J., Steele V.E., Pezzuto J.M. Modulation of in vitro biomarkers of the carcinogenic process by chemopreventive agents. Anticancer Res. 19:1999;35.
26. Iwashita K., Kobori M., Yamaki K., Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci. Biotechnol. Biochem. 64:2000;1813.